Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 27, 2015	Sep. 28, 2014
Cash flows from operating activities:
Net income (loss)	$ (8.0)	$ 7.5
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	103.0	102.5
Non-cash stock-based compensation expense	23.6	25.0
Non-cash restructuring and impairments expense	0.8	1.5
Non-cash financing expense	1.1	0.9
Gain from sale of equity investment		(1.4)
Goodwill impairment charge	0.6
Loss on disposal of property, plant and equipment	0.7	1.9
Deferred income taxes, net	(0.3)	(5.9)
Charge for litigation		4.4
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	(33.9)	(13.7)
Inventories	(39.1)	(24.2)
Other current assets	(5.1)	0.8
Accounts payable	12.6	16.4
Accrued expenses and other current liabilities	(19.7)	13.0
Other assets and liabilities, net	3.4	18.7
Net cash provided by operating activities	39.7	147.4
Cash flows from investing activities:
Capital expenditures	(50.8)	(41.3)
Proceeds from the sale of property, plant and equipment, net	7.1
Purchase of molds and tooling	(1.0)	(1.8)
Maturity of marketable securities	0.1
Sale of equity investment		2.1
Acquisitions and divestitures, net of cash acquired		(56.6)
Net cash used in investing activities	(44.6)	(97.6)
Cash flows from financing activities:
Repayment of long-term debt		(200.0)
Issuance of long-term debt		200.0
Proceeds from issuance of stock for share-based compensation arrangements	1.4	1.4
Purchase of treasury stock	(95.7)	(124.6)
Shares withheld for employee taxes	(10.7)	(7.7)
Debt financing costs	(0.1)	(1.7)
Net cash used in financing activities	(105.1)	(132.6)
Net change in cash and cash equivalents	(110.0)	(82.8)
Cash and cash equivalents at beginning of period	352.9	417.8
Cash and cash equivalents at end of period	$ 242.9	$ 335.0